ArticleCancer immunology, immunotherapy : CII2025

CD40 transcriptomic expression patterns across malignancies: implications for clinical trials of CD40 agonists.

Yuji Uehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.